About Kate Garrett
Kate Garrett is co-founder and managing partner of Sonder Capital, an early-stage healthcare venture firm that named her managing partner in April 2024. She sits on the boards of BRIUS, Spirair and Neptune Medical, and she is associate director of the Stanford Biodesign Innovation Fellowship. Sonder Capital took part in BRIUS's Series B in 2025.
Earlier she co-founded Ciel Medical in 2012 and ran it as CEO. Vyaire Medical acquired it in 2017, and she then served as vice president of airway technologies at Vyaire. She also worked as a strategic marketing consultant at Acclarent and as an R&D engineer at Pathway Medical, and she has advised Jackson Medical.
Experience
This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Kate Garrett in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Kate Garrett works with at each company, as listed on that company's latest Form D.
Kate Garrett in the News
- Sonder Capital: Second Fund Futures II Closed To Advance AI-Enabled Medical Robotics And Minimally Invasive Therapies
- Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
- Sonder Capital Appoints Kate Garrett as Managing Partner
- Benjamin Bishop Named CEO of Spirair
Sources
- SECBRIUS Technologies, Inc. Form D, filed Jul 23, 2026
- SECSpirair, Inc. Form D/A, filed Mar 10, 2026
- Press releaseSonder Capital appoints Kate Garrett as Managing Partner, Business Wire, April 2, 2024
- University siteStanford Biodesign: Ciel Medical, founded 2012 by Kate Garrett and Dan Azagury, acquired by Vyaire Medical in 2017
- University siteStanford Biodesign: Kate Garrett, CEO and Co-Founder of Ciel Medical
- Company press releaseBRIUS names Lea A. Ellermeier CEO, January 2023 (quotes Kate Garrett, Managing Partner at Sonder Capital)